These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Synergistic copathogens--HIV-1 and HSV-2. Corey L. N Engl J Med; 2007 Feb 22; 356(8):854-6. PubMed ID: 17314346 [No Abstract] [Full Text] [Related]
23. Genital herpes simplex virus infection and perinatal transmission of human immunodeficiency virus. Chen KT, Segú M, Lumey LH, Kuhn L, Carter RJ, Bulterys M, Abrams EJ, New York City Perinatal AIDS Collaborative Transmission Study (PACTS) Group. Obstet Gynecol; 2005 Dec 22; 106(6):1341-8. PubMed ID: 16319261 [Abstract] [Full Text] [Related]
24. Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donations. Benjamin RJ, Busch MP, Fang CT, Notari EP, Puren A, Schoub BD, Tobler LH, Hogrefe W, du P Heyns A, Stramer SL, Crookes RL. Transfusion; 2008 Feb 22; 48(2):295-303. PubMed ID: 18005322 [Abstract] [Full Text] [Related]
26. Herpes simplex virus type 2 infection does not influence viral dynamics during early HIV-1 infection. Cachay ER, Frost SD, Richman DD, Smith DM, Little SJ. J Infect Dis; 2007 May 01; 195(9):1270-7. PubMed ID: 17396995 [Abstract] [Full Text] [Related]
27. High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study. Brown EL, Wald A, Hughes JP, Morrow RA, Krantz E, Mayer K, Buchbinder S, Koblin B, Celum C. Am J Epidemiol; 2006 Oct 15; 164(8):733-41. PubMed ID: 16896053 [Abstract] [Full Text] [Related]
29. Modeling the synergy between HSV-2 and HIV and potential impact of HSV-2 therapy. Feng Z, Qiu Z, Sang Z, Lorenzo C, Glasser J. Math Biosci; 2013 Oct 15; 245(2):171-87. PubMed ID: 23850537 [Abstract] [Full Text] [Related]
30. Herpes simplex virus type 2: epidemiology and management options in developing countries. Paz-Bailey G, Ramaswamy M, Hawkes SJ, Geretti AM. Postgrad Med J; 2008 Jun 15; 84(992):299-306. PubMed ID: 18644920 [Abstract] [Full Text] [Related]
32. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes. Sperling RS, Fife KH, Warren TJ, Dix LP, Brennan CA. Sex Transm Dis; 2008 Mar 15; 35(3):286-90. PubMed ID: 18157071 [Abstract] [Full Text] [Related]
33. Herpes simplex virus and HIV: genital infection synergy and novel approaches to dual prevention. Thurman AR, Doncel GF. Int J STD AIDS; 2012 Sep 15; 23(9):613-9. PubMed ID: 23033511 [Abstract] [Full Text] [Related]
34. The pathogenesis underlying the interaction of HIV and herpes simplex virus after co-infection. Cunningham AL, Dwyer DE. J HIV Ther; 2004 Feb 15; 9(1):9-13. PubMed ID: 15071424 [Abstract] [Full Text] [Related]
38. Herpes simplex virus type 2 enhances HIV-1 susceptibility by affecting Langerhans cell function. de Jong MA, de Witte L, Taylor ME, Geijtenbeek TB. J Immunol; 2010 Aug 01; 185(3):1633-41. PubMed ID: 20592277 [Abstract] [Full Text] [Related]
39. Outbreaks of genital herpes: effects on plasma HIV type 1 viral loads in individuals receiving highly active antiretroviral therapy. Lee V, Foley E, Barton SE, Patel R. J Infect Dis; 2004 Dec 01; 190(11):2057-8. PubMed ID: 15529276 [No Abstract] [Full Text] [Related]
40. Herpes simplex virus type 2 (HSV-2) seroprevalence at the time of HIV-1 diagnosis and seroincidence after HIV-1 diagnosis in an ethnically diverse cohort of HIV-1-infected persons. Ramaswamy M, Sabin C, McDonald C, Smith M, Taylor C, Geretti AM. Sex Transm Dis; 2006 Feb 01; 33(2):96-101. PubMed ID: 16432480 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]